COVID-19
Decode Complexities of COVID-19 and Other Infectious Diseases
Genomic insights are crucial to better understand the complexities of emerging infections. HTG’s EdgeSeq technology for gene expression profiling can rapidly evaluate comprehensive immune gene expression changes in response to infection, identify key transcriptional changes that occur during viral pathogenesis and discover the effects of preventative and therapeutic interventions.
Investigate Different Stages of Infectious Disease
Measure Genes for Severity of Immune Response
Time Course and Recovery Measurement
Generate GEP Data That Facilitates Drug Discovery of Novel Therapeutics
Investigate Different Stages of Infectious Disease
Measure Genes for Severity of Immune Response to Infection
Exploring immune response during COVID-19 infection has become an important tool to develop disease management strategies. Recent discoveries have shown that people predisposed to producing auto-antibodies are more likely to suffer targeted long-term damage. Understanding the host’s transcriptional response to infection is critical in understanding the disparity in response. HTG EdgeSeq Immune Response Panel offers a robust solution to better understand viral infections including SARS-CoV-2.
Time Course and Recovery Management
Discovery of biomarkers involved in innate immune response over the course of infection can provide key insights into the cellular and molecular mechanisms of COVID-19 disease. Understanding cellular response to viral infections like SARS-CoV-2 is critical to making advances in treatment therapies, recovery and management of long-term effects of the disease.
Drug Discovery of Novel Therapeutics
Gene expression analysis can accelerate drug discovery by identifying and validating molecular pathways affected by the disease progression. Insights from pathway analysis can be used to focus discovery efforts for novel therapeutics strategies.
